A new compound preparation for the treatment of skin disorders.
D000777:Anesthetics / Q000009:adverse effects / Q000627:therapeutic use*; D000891:Anti-Infective Agents, Local / Q000009:adverse effects / Q000627:therapeutic use*; D002713:Chlorine / Q000627:therapeutic use; D003872:Dermatitis / Q000188:drug therapy; D012628:Dermatitis, Seborrheic / Q000188:drug therapy; D003879:Dermatologic Agents / Q000627:therapeutic use; D003907:Dexamethasone / Q000009:adverse effects / Q000627:therapeutic use*; D004485:Eczema / Q000188:drug therapy; D006590:Hexetidine / Q000627:therapeutic use; D006801:Humans; D009277:Nandrolone / Q000009:adverse effects / Q000627:therapeutic use*; D009450:Neurodermatitis / Q000188:drug therapy; D010032:Otitis Externa / Q000188:drug therapy; D011536:Prurigo / Q000188:drug therapy; D011537:Pruritus / Q000188:drug therapy; D011565:Psoriasis / Q000188:drug therapy; D011743:Pyrimidines / Q000627:therapeutic use*; D012871:Skin Diseases / Q000188:drug therapy*
D000777:Anesthetics; D000891:Anti-Infective Agents, Local; D003879:Dermatologic Agents; D011743:Pyrimidines; D002713:Chlorine; D009277:Nandrolone; D003907:Dexamethasone; D006590:Hexetidine